康孅伴膠囊錠60毫克

Country: Taiwan

Language: Chinese

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Active ingredient:

SODIUM LAURYL SULFATE;;POVIDONE (EQ TO POLYVINYL PYRROLIDONE)( EQ TO PVP ) ( EQ TO POLYVIDONE)(EQ TO POLYVINYLPYRROLIDONE);;CELLULOSE MICROCRYSTALLINE (MICROCRYSTALLINE CELLULOSE);;SODIUM STARCH GLYCOLATE;;TALC;;ORLISTAT

Available from:

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438)

ATC code:

A08AB01

Pharmaceutical form:

膠囊劑

Composition:

ORLISTAT (1212004500) MG; SODIUM LAURYL SULFATE (8420000600) MG; CELLULOSE MICROCRYSTALLINE (MICROCRYSTALLINE CELLULOSE) (9600006902) MG; POVIDONE (EQ TO POLYVINYL PYRROLIDONE)( EQ TO PVP ) ( EQ TO POLYVIDONE)(EQ TO POLYVINYLPYRROLIDONE) (9600024500) MG; SODIUM STARCH GLYCOLATE (9600028700) MG; TALC (9600031309) MG

Units in package:

塑膠瓶裝

Class:

製　劑

Prescription type:

醫師藥師藥劑生指示藥品

Manufactured by:

GLAXOSMITHKLINE CONSUMER HEALTHCARE, L.P VERENES INDUSTRIAL PARK, 65 WINDHAM BOULEVARD, AIKEN, SOUTH CAROLINA 29805, USA US

Therapeutic area:

orlistat

Therapeutic indications:

輔助減重。針對十八歲以上之體重過重(BMI大於等於25kg/m2)成人，配合低卡路里、低脂飲食使用。

Product summary:

註銷日期: 2016/05/30; 註銷理由: 許可證已逾有效期; 有效日期: 2015/01/06; 英文品名: Alli Capsules 60mg

Authorization status:

已註銷

Authorization date:

2010-01-06